Åse Rosenqvist

Mrs. Rosenqvist holds a position on the Board of CAMP ATMP Sweden and serves as the Nordic Cell Therapy lead at Janssen, a division of Johnson&Johnson. Her expertise lies in guiding pharmaceutical companies toward innovative approaches in Europe. She excels at fostering collaboration among various stakeholders within the healthcare system, academia, universities, authorities, and the life science sector. Through her inclusive and inspiring leadership style, she empowers individuals and harnesses their potential.